| NRF2, a transcription factor for stress response and beyond F He, X Ru, T Wen International journal of molecular sciences 21 (13), 4777, 2020 | 1236 | 2020 |
| NF-κB restricts inflammasome activation via elimination of damaged mitochondria Z Zhong, A Umemura, E Sanchez-Lopez, S Liang, S Shalapour, J Wong, ... Cell 164 (5), 896-910, 2016 | 1110 | 2016 |
| New mitochondrial DNA synthesis enables NLRP3 inflammasome activation Z Zhong, S Liang, E Sanchez-Lopez, F He, S Shalapour, X Lin, J Wong, ... Nature 560 (7717), 198-203, 2018 | 1000 | 2018 |
| p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells A Umemura, F He, K Taniguchi, H Nakagawa, S Yamachika, ... Cancer cell 29 (6), 935-948, 2016 | 456 | 2016 |
| NRF2 as a regulator of cell metabolism and inflammation in cancer F He, L Antonucci, M Karin Carcinogenesis 41 (4), 405-416, 2020 | 280 | 2020 |
| An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis P Zhao, X Sun, C Chaggan, Z Liao, K In Wong, F He, S Singh, R Loomba, ... Science 367 (6478), 652-660, 2020 | 257 | 2020 |
| A short Nur77-derived peptide converts Bcl-2 from a protector to a killer SK Kolluri, X Zhu, X Zhou, B Lin, Y Chen, K Sun, X Tian, J Town, X Cao, ... Cancer cell 14 (4), 285-298, 2008 | 251 | 2008 |
| ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis F He, P Zhang, J Liu, R Wang, RJ Kaufman, BC Yaden, M Karin Journal of hepatology 79 (2), 362-377, 2023 | 160 | 2023 |
| p62/SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer K Taniguchi, S Yamachika, F He, M Karin FEBS letters 590 (15), 2375-2397, 2016 | 126 | 2016 |
| BH 3‐in‐groove dimerization initiates and helix 9 dimerization expands Bax pore assembly in membranes Z Zhang, S Subramaniam, J Kale, C Liao, B Huang, H Brahmbhatt, ... The EMBO journal 35 (2), 208-236, 2016 | 108 | 2016 |
| NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly F He, L Antonucci, S Yamachika, Z Zhang, K Taniguchi, A Umemura, ... Journal of hepatology 72 (6), 1182-1195, 2020 | 101 | 2020 |
| Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease MF Yueh, F He, C Chen, C Vu, A Tripathi, R Knight, M Karin, S Chen, ... Proceedings of the National Academy of Sciences 117 (49), 31259-31266, 2020 | 60 | 2020 |
| Reactive oxygen species and NRF2 signaling, friends or foes in cancer? R Wang, L Liang, M Matsumoto, K Iwata, A Umemura, F He Biomolecules 13 (2), 353, 2023 | 58 | 2023 |
| Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist Q Fang, YQ Wang, F He, J Guo, Q Chen, R Wang Regulatory peptides 147 (1-3), 45-51, 2008 | 58 | 2008 |
| Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule L Zhao, F He, H Liu, Y Zhu, W Tian, P Gao, H He, W Yue, X Lei, B Ni, ... Journal of Biological Chemistry 287 (2), 1054-1065, 2012 | 52 | 2012 |
| In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist Q Fang, J Guo, F He, Y Peng, M Chang, R Wang Peptides 27 (9), 2207-2213, 2006 | 49 | 2006 |
| Development of flexible-heteroarotinoids for kidney cancer T Liu, CP Masamha, S Chengedza, KD Berlin, S Lightfoot, F He, ... Molecular cancer therapeutics 8 (5), 1227-1238, 2009 | 46 | 2009 |
| From liver fat to cancer: perils of the western diet JY Kim, F He, M Karin Cancers 13 (5), 1095, 2021 | 33 | 2021 |
| Amphipathic Tail-anchoring Peptide and Bcl-2 Homology Domain-3 (BH3) Peptides from Bcl-2 Family Proteins Induce Apoptosis through Different Mechanisms*♦ JK Ko, KH Choi, J Peng, F He, Z Zhang, N Weisleder, J Lin, J Ma Journal of Biological Chemistry 286 (11), 9038-9048, 2011 | 33 | 2011 |
| Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: a comprehensive review with future perspectives R Wang, C Wang, L Lu, F Yuan, F He Pharmacological Research 199, 107032, 2024 | 29 | 2024 |
Miguel Reina-CamposLa Jolla Institute for ImmunologyBestätigte E-Mail-Adresse bei lji.org
